• 31324 Citations
1984 …2027
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1984 2019

Filter
Article
2019

Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance)

Morales-Oyarvide, V., Yuan, C., Babic, A., Zhang, S., Niedzwiecki, D., Brand-Miller, J. C., Sampson-Kent, L., Ye, X., Li, Y., Saltz, L. B., Mayer, R. J., Mowat, R. B., Whittom, R., Hantel, A., Benson III, A. B., Atienza, D., Messino, M., Kindler, H., Venook, A., Ogino, S. & 7 othersWu, K., Willett, W. C., Giovannucci, E. L., Wolpin, B. M., Meyerhardt, J. A., Fuchs, C. S. & Ng, K., Feb 1 2019, In : Journal of the National Cancer Institute. 111, 2, p. 170-179 10 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Insulin
Recurrence
Survival
Neoplasms

Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies

Lentz, R., Benson III, A. B. & Kircher, S. M., Jan 1 2019, (Accepted/In press) In : Journal of Surgical Oncology.

Research output: Contribution to journalArticle

Neoplasms
Psychology
Costs and Cost Analysis
Health

Real-World Treatment Patterns and Clinical Outcomes in Advanced Gastrointestinal Neuroendocrine Tumors (GI NET): A Multicenter Retrospective Chart Review Study

Kulke, M. H., Benson III, A. B., Dasari, A., Huynh, L., Cai, B., Totev, T., Roesner, N., Duh, M. S., Neary, M. P., Maurer, V. E., Shih, B. E., Dagohoy, C. G., Chan, J. & Bergsland, E. K., Jan 1 2019, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Therapeutics
Somatostatin
Drug Therapy
Interferons

Therasphere yttrium-90 glass microspheres combined with chemotherapy versus chemotherapy alone in second-line treatment of patients with metastatic colorectal carcinoma of the liver: Protocol for the EPOCH phase 3 randomized clinical trial

Chauhan, N., Mulcahy, M. F., Salem, R., Benson III, A. B., Boucher, E., Bukovcan, J., Cosgrove, D., Laframboise, C., Lewandowski, R. J., Master, F., El-Rayes, B., Strosberg, J. R., Sze, D. Y. & Sharma, R. A., Jan 1 2019, In : Journal of medical Internet research. 21, 1, e11545.

Research output: Contribution to journalArticle

Yttrium
Phase III Clinical Trials
Microspheres
Glass
Colorectal Neoplasms

Treatment Patterns and Clinical Outcomes in Advanced Lung Neuroendocrine Tumors in Real-World Settings: A Multicenter Retrospective Chart Review Study

Dasari, A., Bergsland, E. K., Benson III, A. B., Cai, B., Huynh, L., Totev, T., Shea, J., Duh, M. S., Neary, M. P., Dagohoy, C. G., Shih, B. E., Maurer, V. E., Chan, J. & Kulke, M. H., Jan 1 2019, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Lung
Somatostatin
Therapeutics
Drug Therapy
2018
2 Citations (Scopus)

An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204)

Berlin, J. D., Feng, Y., Catalano, P., Abbruzzese, J. L., Philip, P. A., McWilliams, R. R., Lowy, A. M., Benson, A. B. & Blackstock, A. W., Jan 1 2018, In : Oncology (Switzerland). 94, 1, p. 39-46 8 p.

Research output: Contribution to journalArticle

gemcitabine
Research
Neoplasms
Disease-Free Survival
Therapeutics
5 Citations (Scopus)

A Phase II Study of Celecoxib with Irinotecan, 5-Fluorouracil, and Leucovorin in Patients with Previously Untreated Advanced or Metastatic Colorectal Cancer

Chen, E. Y., Blanke, C. D., Haller, D. G., Benson III, A. B., Dragovich, T., Lenz, H. J., Robles, C., Li, H., Mori, M., Mattek, N., Sanborn, R. E. & Lopez, C. D., Dec 1 2018, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 12, p. 1193-1198 6 p.

Research output: Contribution to journalArticle

irinotecan
Celecoxib
Leucovorin
Fluorouracil
Colorectal Neoplasms
7 Citations (Scopus)

Association of survival with adherence to the American cancer society nutrition and physical activity guidelines for cancer survivors after colon cancer diagnosis the calgb 89803/alliance trial

Van Blarigan, E. L., Fuchs, C. S., Niedzwiecki, D., Zhang, S., Saltz, L. B., Mayer, R. J., Mowat, R. B., Whittom, R., Hantel, A., Benson III, A. B., Atienza, D., Messino, M., Kindler, H., Venook, A., Ogino, S., Giovannucci, E. L., Ng, K. & Meyerhardt, J. A., Jun 1 2018, In : JAMA Oncology. 4, 6, p. 783-790 8 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Survivors
Guidelines
Exercise
Confidence Intervals

Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance)

Guercio, B. J., Zhang, S., Niedzwiecki, D., Li, Y., Babic, A., Morales-Oyarvide, V., Saltz, L. B., Mayer, R. J., Mowat, R. B., Whittom, R., Hantel, A., Benson III, A. B., Atienza, D., Messino, M., Kindler, H., Venook, A., Ogino, S., Zoltick, E. S., Stampfer, M., Ng, K. & 5 othersWu, K., Willett, W. C., Giovannucci, E. L., Meyerhardt, J. A. & Fuchs, C. S., Jul 1 2018, In : PloS one. 13, 7, e0199244.

Research output: Contribution to journalArticle

Beverages
relapse
colorectal neoplasms
Colonic Neoplasms
beverages
1 Citation (Scopus)

Dietary fat intake after colon cancer diagnosis in relation to cancer recurrence and survival: CALGB 89803 (Alliance)

Van Blarigan, E. L., Ou, F. S., Niedzwiecki, D., Zhang, S., Fuchs, C. S., Saltz, L., Mayer, R. J., Venook, A., Ogino, S., Song, M., Benson III, A. B., Hantel, A., Atkins, J. N., Giovannucci, E. L. & Meyerhardt, J. A., Oct 1 2018, In : Cancer Epidemiology Biomarkers and Prevention. 27, 10, p. 1227-1230 4 p.

Research output: Contribution to journalArticle

Dietary Fats
Colonic Neoplasms
Recurrence
Survival
Vegetables
1 Citation (Scopus)

E4206: AMG 706 and Octreotide in Patients with Low-Grade Neuroendocrine Tumors

Lubner, S., Feng, Y., Mulcahy, M. F., O'Dwyer, P., Giang, G. Y., Hinshaw, J. L., Deming, D., Klein, L., Teitelbaum, U., Payne, J., Engstrom, P., Stella, P., Meropol, N. & Benson III, A. B., Sep 1 2018, In : Oncologist. 23, 9, p. 1006-e104

Research output: Contribution to journalArticle

Octreotide
Neuroendocrine Tumors
Disease-Free Survival
Vascular Endothelial Growth Factor A
Fatigue
1 Citation (Scopus)

First-line systemic treatment adherence, healthcare resource utilization, and costs in patients with gastrointestinal neuroendocrine tumors (GI NETs) in the USA

Broder, M. S., Cai, B., Chang, E., Yan, T. & Benson III, A. B., Aug 3 2018, In : Journal of Medical Economics. 21, 8, p. 821-826 6 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Delivery of Health Care
Costs and Cost Analysis
Somatostatin
Drug Therapy
1 Citation (Scopus)

From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing

Trosman, J. R., Weldon, C. B., Gradishar, W. J., Benson III, A. B., Cristofanilli, M., Kurian, A. W., Ford, J. M., Balch, A., Watkins, J. & Phillips, K. A., Sep 1 2018, In : Value in Health. 21, 9, p. 1062-1068 7 p.

Research output: Contribution to journalArticle

Insurance Carriers
Neoplasms
Medicare
Technology
Precision Medicine
20 Citations (Scopus)

Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience

Salem, R., Gabr, A., Riaz, A., Mora, R., Ali, R., Abecassis, M., Hickey, R., Kulik, L., Ganger, D., Flamm, S., Atassi, R., Atassi, B., Sato, K., Benson, A. B., Mulcahy, M. F., Abouchaleh, N., Asadi, A. A., Desai, K., Thornburg, B., Vouche, M. & 7 othersHabib, A., Caicedo, J., Miller, F. H., Yaghmai, V., Kallini, J. R., Mouli, S. & Lewandowski, R. J., Oct 1 2018, In : Hepatology. 68, 4, p. 1429-1440 12 p.

Research output: Contribution to journalArticle

Liver Neoplasms
Hepatocellular Carcinoma
Confidence Intervals
Survival
Therapeutics
1 Citation (Scopus)
Yttrium
Microspheres
Glass
Hepatocellular Carcinoma
Randomized Controlled Trials
4 Citations (Scopus)

Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma: A Phase 2 Clinical Trial

Sahai, V., Catalano, P. J., Zalupski, M. M., Lubner, S. J., Menge, M. R., Nimeiri, H. S., Munshi, H. G., Benson III, A. B. & O'Dwyer, P. J., Dec 1 2018, In : JAMA Oncology. 4, 12, p. 1707-1712 6 p.

Research output: Contribution to journalArticle

gemcitabine
Cholangiocarcinoma
Clinical Trials
Disease-Free Survival
Nanoparticles
8 Citations (Scopus)

Nut consumption and survival in patients with stage III colon cancer: Results from CALGB 89803 (Alliance)

Fadelu, T., Zhang, S., Niedzwiecki, D., Ye, X., Saltz, L. B., Mayer, R. J., Mowat, R. B., Whittom, R., Hantel, A., Benson III, A. B., Atienza, D. M., Messino, M., Kindler, H. L., Venook, A., Ogino, S., Ng, K., Wu, K., Willett, W., Giovannucci, E., Meyerhardt, J. & 2 othersBao, Y. & Fuchs, C. S., Apr 10 2018, In : Journal of Clinical Oncology. 36, 11, p. 1112-1120 9 p.

Research output: Contribution to journalArticle

Nuts
Colonic Neoplasms
Survival
Recurrence
Type 2 Diabetes Mellitus
1 Citation (Scopus)

Pembrolizumab for the treatment of gastric cancer

Kamath, S. D., Kalyan, A. & Benson III, A. B., Dec 2 2018, In : Expert Review of Anticancer Therapy. 18, 12, p. 1177-1187 11 p.

Research output: Contribution to journalArticle

Stomach Neoplasms
Immunotherapy
Stomach
Dysbiosis
Therapeutics
61 Citations (Scopus)

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

KEYNOTE-061 investigators, Jul 14 2018, In : The Lancet. 392, 10142, p. 123-133 11 p.

Research output: Contribution to journalArticle

Esophageal Neoplasms
Paclitaxel
Stomach
Cell Death
Survival

Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG-ACRIN Cancer Research Group (E4203)

Meropol, N. J., Feng, Y., Grem, J. L., Mulcahy, M. F., Catalano, P. J., Kauh, J. S., Hall, M. J., Saltzman, J. N., George, T. J., Zangmeister, J., Chiorean, E. G., Cheema, P. S., O'Dwyer, P. J. & Benson, A. B., Feb 15 2018, In : Cancer. 124, 4, p. 688-697 10 p.

Research output: Contribution to journalArticle

oxaliplatin
irinotecan
Thymidylate Synthase
Colorectal Neoplasms
Research
1 Citation (Scopus)

Real-World Treatment Patterns for Lung Neuroendocrine Tumors: A Claims Database Analysis

Broder, M. S., Cai, B., Chang, E., Neary, M. P., Papoyan, E. & Benson III, A. B., Apr 1 2018, In : Oncology (Switzerland). 94, 5, p. 281-288 8 p.

Research output: Contribution to journalArticle

Insurance Claim Review
Neuroendocrine Tumors
Databases
Lung
Somatostatin

Treatment adherence, healthcare resource utilization, and costs in patients with lung neuroendocrine tumors (lung NETs) in the USA

Broder, M. S., Cai, B., Chang, E., Yan, T. & Benson III, A. B., Dec 2 2018, In : Current Medical Research and Opinion. 34, 12, p. 2151-2156 6 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Somatostatin
Delivery of Health Care
Costs and Cost Analysis
Drug Therapy
1 Citation (Scopus)

Trends in intensity modulated radiation therapy use for locally advanced rectal cancer at National Comprehensive Cancer Network centers

Reyngold, M., Niland, J., ter Veer, A., Bekaii-Saab, T., Lai, L., Meyer, J. E., Nurkin, S. J., Schrag, D., Skibber, J. M., Benson III, A. B., Weiser, M. R., Crane, C. H. & Goodman, K. A., Jan 1 2018, In : Advances in Radiation Oncology. 3, 1, p. 34-41 8 p.

Research output: Contribution to journalArticle

Rectal Neoplasms
Radiotherapy
Neoplasms
Comparative Effectiveness Research
African Americans
2017
13 Citations (Scopus)

A blueprint to advance colorectal cancer immunotherapies

Le, D. T., Hubbard-Lucey, V. M., Morse, M. A., Heery, C. R., Dwyer, A., Marsilje, T. H., Brodsky, A. N., Chan, E., Deming, D. A., Diaz, L. A., Fridman, W. H., Goldberg, R. M., Hamilton, S. R., Housseau, F., Jaffee, E. M., Kang, S. P., Krishnamurthi, S. S., Lieu, C. H., Messersmith, W., Sears, C. L. & 10 othersSegal, N. H., Yang, A., Moss, R. A., Cha, E., O'Donnell-Tormey, J., Roach, N., Davis, A. Q., McAbee, K., Worrall, S. & Benson III, A. B., Nov 1 2017, In : Cancer Immunology Research. 5, 11, p. 942-949 8 p.

Research output: Contribution to journalArticle

Immunotherapy
Colorectal Neoplasms
Microsatellite Repeats
T-Lymphocytes
Biomarkers
2 Citations (Scopus)

A need to simplify informed consent documents in cancer clinical trials. A position paper of the ARCAD Group

Bleiberg, H., Decoster, G., de Gramont, A., Rougier, P., Sobrero, A., Benson III, A. B., Chibaudel, B., Douillard, J. Y., Eng, C., Fuchs, C., Fujii, M., Labianca, R., Larsen, A. K., Mitchell, E., Schmoll, H. J., Sprumont, D. & Zalcberg, J., May 1 2017, In : Annals of oncology : official journal of the European Society for Medical Oncology. 28, 5, p. 922-930 9 p.

Research output: Contribution to journalArticle

Consent Forms
Informed Consent
Clinical Trials
Documentation
Neoplasms
13 Citations (Scopus)

A phase II, randomized, double-blind, placebo-controlled study of simtuzumab in combination with FOLFIRI for the Second-Line treatment of metastatic KRAS mutant colorectal adenocarcinoma

Randolph Hecht, J., Benson, A. B., Vyushkov, D., Yang, Y., Bendell, J. & Verma, U., Mar 1 2017, In : Oncologist. 22, 3

Research output: Contribution to journalArticle

Colorectal Neoplasms
Adenocarcinoma
Placebos
irinotecan
Disease-Free Survival
15 Citations (Scopus)

A phase II randomized, double-blind, placebo-controlled study of simtuzumab or placebo in combination with gemcitabine for the first-line treatment of pancreatic adenocarcinoma

Benson, A. B., Wainberg, Z. A., Randolph Hecht, J., Vyushkov, D., Dong, H., Bendell, J. & Kudrik, F., Mar 1 2017, In : Oncologist. 22, 3

Research output: Contribution to journalArticle

gemcitabine
Adenocarcinoma
Placebos
Therapeutics
Disease-Free Survival
14 Citations (Scopus)

Cetuximab plus chemoradiotherapy in immunocompetent patients with anal carcinoma: A phase II Eastern cooperative oncology group-American college of radiology imaging network cancer research group trial (E3205)

Garg, M. K., Zhao, F., Sparano, J. A., Palefsky, J., Whittington, R., Mitchell, E. P., Mulcahy, M. F., Armstrong, K. I., Nabbout, N. H., Kalnicki, S., El-Rayes, B. F., Onitilo, A. A., Moriarty, D. J., Fitzgerald, T. J. & Benson, A. B., Mar 1 2017, In : Journal of Clinical Oncology. 35, 7, p. 718-726 9 p.

Research output: Contribution to journalArticle

Chemoradiotherapy
Radiology
Anal Canal
Squamous Cell Carcinoma
Papillomaviridae
4 Citations (Scopus)

Comparing the cost of treatment with octreotide long-acting release versus lanreotide in patients with metastatic gastrointestinal neuroendocrine tumors

Ayyagari, R., Neary, M., Li, S., Rokito, A., Yang, H., Xie, J. & Benson, A. B., Nov 1 2017, In : American Health and Drug Benefits. 10, 8, p. 408-415 8 p.

Research output: Contribution to journalArticle

Octreotide
Neuroendocrine Tumors
Health Care Costs
Costs and Cost Analysis
Drug Costs

Cost reduction from resolution/improvement of carcinoid syndrome symptoms following treatment with above-standard dose of octreotide LAR

Huynh, L., Totev, T., Vekeman, F., Neary, M. P., Duh, M. S. & Benson III, A. B., Sep 2 2017, In : Journal of Medical Economics. 20, 9, p. 945-951 7 p.

Research output: Contribution to journalArticle

Octreotide
Carcinoid Tumor
Diarrhea
Neuroendocrine Tumors
Costs and Cost Analysis
120 Citations (Scopus)

Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer a randomized clinical trial

Venook, A. P., Niedzwiecki, D., Lenz, H. J., Innocenti, F., Fruth, B., Meyerhardt, J. A., Schrag, D., Greene, C., O'Neil, B. H., Atkins, J. N., Berry, S., Polite, B. N., O'Reilly, E. M., Goldberg, R. M., Hochster, H. S., Schilsky, R. L., Bertagnolli, M. M., El-Khoueiry, A. B., Watson, P., Benson III, A. B. & 3 othersMulkerin, D. L., Mayer, R. J. & Blanke, C., Jun 20 2017, In : JAMA - Journal of the American Medical Association. 317, 23, p. 2392-2401 10 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Randomized Controlled Trials
Drug Therapy
Survival
oxaliplatin
54 Citations (Scopus)

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology

Bartley, A. N., Washington, M. K., Colasacco, C., Ventura, C. B., Ismaila, N., Benson III, A. B., Carrato, A., Gulley, M. L., Jain, D., Kakar, S., Mackay, H. J., Streutker, C., Tang, L., Troxell, M. & Ajani, J. A., Feb 1 2017, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 35, 4, p. 446-464 19 p.

Research output: Contribution to journalArticle

Adenocarcinoma
Guidelines
TYK2 Kinase
Clinical Decision-Making
Pathologists
8 Citations (Scopus)
Yttrium
Neuroendocrine Tumors
Liver
Fibrosis
Therapeutics
411 Citations (Scopus)

Phase 3 trial of 177lu-dotatate for midgut neuroendocrine tumors

Strosberg, J., El-Haddad, G., Wolin, E., Hendifar, A., Yao, J., Chasen, B., Mittra, E., Kunz, P. L., Kulke, M. H., Jacene, H., Bushnell, D., O'Dorisio, T. M., Baum, R. P., Kulkarni, H. R., Caplin, M., Lebtahi, R., Hobday, T., Delpassand, E., Van Cutsem, E., Benson, A. & 15 othersSrirajaskanthan, R., Pavel, M., Mora, J., Berlin, J., Grande, E., Reed, N., Seregni, E., Öberg, K., Sierra, M. L., Santoro, P., Thevenet, T., Erion, J. L., Ruszniewski, P., Kwekkeboom, D. & Krenning, E., Jan 12 2017, In : New England Journal of Medicine. 376, 2, p. 125-135 11 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Octreotide
Survival Analysis
Control Groups
Disease-Free Survival
9 Citations (Scopus)

Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance)

Fuchs, M. A., Yuan, C., Sato, K., Niedzwiecki, D., Ye, X., Saltz, L. B., Mayer, R. J., Mowat, R. B., Whittom, R., Hantel, A., Benson III, A. B., Atienza, D., Messino, M., Kindler, H., Venook, A., Innocenti, F., Warren, R. S., Bertagnolli, M. M., Ogino, S., Giovannucci, E. L. & 3 othersHorvath, E., Meyerhardt, J. A. & Ng, K., Jun 1 2017, In : Annals of Oncology. 28, 6, p. 1359-1367 9 p., mdx109.

Research output: Contribution to journalArticle

Vitamin D
Colonic Neoplasms
Recurrence
Mortality
Survival
1 Citation (Scopus)

Real-world treatment patterns of gastrointestinal neuroendocrine tumors: A claims database analysis

Benson III, A. B., Broder, M. S., Cai, B., Chang, E., Neary, M. P. & Papoyan, E., Sep 7 2017, In : World Journal of Gastroenterology. 23, 33, p. 6128-6136 9 p.

Research output: Contribution to journalArticle

Insurance Claim Review
Neuroendocrine Tumors
Databases
Somatostatin
Therapeutics
2016
29 Citations (Scopus)

90Y radioembolization of colorectal hepatic metastases using glass microspheres: Safety and survival outcomes from a 531-patient multicenter study

Hickey, R. M., Lewandowski, R. J., Prudhomme, T., Ehrenwald, E., Baigorri, B., Critchfield, J., Kallini, J., Gabr, A., Gorodetski, B., Geschwind, J. F., Abbott, A., Shridhar, R., White, S. B., Rilling, W. S., Boyer, B., Kauffman, S., Kwan, S., Padia, S. A., Gates, V. L., Mulcahy, M. F. & 4 othersKircher, S. M., Nimeiri, H. S., Benson III, A. B. & Salem, R., May 1 2016, In : Journal of Nuclear Medicine. 57, 5, p. 665-671 7 p.

Research output: Contribution to journalArticle

Eye Protective Devices
Microspheres
Multicenter Studies
Neoplasm Metastasis
Survival
7 Citations (Scopus)

Adjusted hospital sentinel lymph node positivity rates in melanoma a novel potential measure of quality

Kinnier, C. V., Paruch, J. L., Dahlke, A. R., Wayne, J. D., Benson III, A. B., Winchester, D. P. & Bilimoria, K. Y., Jan 1 2016, In : Annals of Surgery. 263, 2, p. 392-398 7 p.

Research output: Contribution to journalArticle

Sentinel Lymph Node Biopsy
Melanoma
Survival
Sentinel Lymph Node
Odds Ratio
4 Citations (Scopus)

BATON-CRC: A phase II randomized trial comparing tivozanib plus mFOLFOX6 with bevacizumab plus mFOLFOX6 in stage IV metastatic colorectal cancer

Benson III, A. B., Kiss, I., Bridgewater, J., Eskens, F. A. L. M., Sasse, C., Vossen, S., Chen, J., Van Sant, C., Ball, H. A., Keating, A. & Krivoshik, A., Oct 15 2016, In : Clinical Cancer Research. 22, 20, p. 5058-5067 10 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Disease-Free Survival
Neuropilin-1
Medical Futility
Biomarkers
30 Citations (Scopus)

CALGB 80403 (Alliance)/E1206: A randomized phase II study of three chemotherapy regimens plus cetuximab in metastatic esophageal and gastroesophageal Junction Cancers

Enzinger, P. C., Burtness, B. A., Niedzwiecki, D., Ye, X., Douglas, K., Ilson, D. H., Villaflor, V. M., Cohen, S. J., Mayer, R. J., Venook, A., Benson, A. B. & Goldberg, R. M., Aug 10 2016, In : Journal of Clinical Oncology. 34, 23, p. 2736-2742 7 p.

Research output: Contribution to journalArticle

Esophagogastric Junction
irinotecan
Cisplatin
Drug Therapy
Epirubicin
6 Citations (Scopus)

Care for a patient with cancer as a project: Management of complex task interdependence in cancer care delivery

Trosman, J. R., Carlos, R. C., Simon, M. A., Madden, D. L., Gradishar, W. J., Benson, A. B., Rapkin, B. D., Weiss, E. S., Gareen, I. F., Wagner, L. I., Khan, S. A., Bunce, M. M., Small, A. & Weldon, C. B., Nov 1 2016, In : Journal of oncology practice. 12, 11, p. 1101-1113 13 p.

Research output: Contribution to journalArticle

Patient Care
Neoplasms
Quality of Health Care
Ataxia
Outcome Assessment (Health Care)
6 Citations (Scopus)
irinotecan
radiology
Radiology
Cisplatin
radiation therapy
536 Citations (Scopus)

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., Ciardiello, F., D'Hoore, A., Diaz-Rubio, E., Douillard, J. Y., Ducreux, M., Falcone, A., Grothey, A., Gruenberger, T., Haustermans, K., Heinemann, V. & 27 othersHoff, P., Köhne, C. H., Labianca, R., Laurent-Puig, P., Ma, B., Maughan, T., Muro, K., Normanno, N., österlund, P., Oyen, W. J. G., Papamichael, D., Pentheroudakis, G., Pfeiffer, P., Price, T. J., Punt, C., Ricke, J., Roth, A., Salazar, R., Scheithauer, W., Schmoll, H. J., Tabernero, J., Taïeb, J., Tejpar, S., Wasan, H., Yoshino, T., Zaanan, A. & Arnold, D., Aug 1 2016, In : Annals of Oncology. 27, 8, p. 1386-1422 37 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Guidelines
Therapeutics
Neoplasms
10 Citations (Scopus)

Financial concerns about participation in clinical trials among patients with cancer

Wong, Y. N., Schluchter, M. D., Albrecht, T. L., Benson III, A. B., Buzaglo, J., Collins, M., Flamm, A. L., Fleisher, L., Katz, M., Kinzy, T. G., Liu, T. M., Manne, S., Margevicius, S., Miller, D. M., Miller, S. M., Poole, D., Raivitch, S., Roach, N., Ross, E. & Meropol, N. J., Feb 10 2016, In : Journal of Clinical Oncology. 34, 5, p. 479-487 9 p.

Research output: Contribution to journalArticle

Clinical Trials
Decision Making
Neoplasms
Self Efficacy
Health Care Costs
29 Citations (Scopus)
Bilirubin
Liver Neoplasms
Albumins
Hepatocellular Carcinoma
Survival
100 Citations (Scopus)

Locally advanced, unresectable pancreatic cancer: American society of clinical oncology clinical practice guideline

Balaban, E. P., Mangu, P. B., Khorana, A. A., Shah, M. A., Mukherjee, S., Crane, C. H., Javle, M. M., Eads, J. R., Allen, P., Ko, A. H., Engebretson, A., Herman, J. M., Strickler, J. H., Benson, A. B., Urba, S. & Yee, N. S., Aug 1 2016, In : Journal of Clinical Oncology. 34, 22, p. 2654-2667 14 p.

Research output: Contribution to journalArticle

Medical Oncology
Pancreatic Neoplasms
Practice Guidelines
Comorbidity
oxaliplatin
6 Citations (Scopus)

Neoadjuvant therapy for rectal cancer affects lymph node yield and status without clear implications on outcome: The case for eliminating a metric and using preoperative staging to guide therapy

Abdel-Misih, S. R. Z., Wei, L., Benson III, A. B., Cohen, S., Lai, L., Skibber, J., Wilkinson, N., Weiser, M., Schrag, D. & Bekaii-Saab, T., Dec 1 2016, In : JNCCN Journal of the National Comprehensive Cancer Network. 14, 12, p. 1528-1534 7 p.

Research output: Contribution to journalArticle

Neoadjuvant Therapy
Rectal Neoplasms
Lymph Nodes
Survival
Drug Therapy
4 Citations (Scopus)

Precision Medicine and Pancreatic Cancer

Farrell, J. J., Moughan, J., Wong, J. L., Regine, W. F., Schaefer, P., Benson III, A. B., Macdonald, J. S., Liu, X., Yen, Y., Lai, R., Zheng, Z., Bepler, G., Guha, C. & Elsaleh, H., Nov 1 2016, In : Pancreas. 45, 10, p. 1485-1493 9 p.

Research output: Contribution to journalArticle

gemcitabine
Precision Medicine
Pancreatic Neoplasms
Deoxycytidine Kinase
Radiation Oncology
9 Citations (Scopus)
oxaliplatin
Peripheral Nervous System Diseases
Neoplasms
Hot Temperature
Skin
7 Citations (Scopus)

Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study

Burtness, B., Powell, M., Catalano, P., Berlin, J., Liles, D. K., Chapman, A. E., Mitchell, E. & Benson III, A. B., Aug 1 2016, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 39, 4, p. 340-345 6 p.

Research output: Contribution to journalArticle

irinotecan
docetaxel
Pancreatic Neoplasms
Disease-Free Survival
Enoxaparin